These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 36903446

  • 1. Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.
    Gu S, Liang J, Zhang J, Liu Z, Miao Y, Wei Y, Li S, Gu J, Cui Y, Xiao T, Li X, Yang C.
    Molecules; 2023 Feb 27; 28(5):. PubMed ID: 36903446
    [Abstract] [Full Text] [Related]

  • 2. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S, Wei Y, Li S, Miao Y, Gu J, Cui Y, Liu Z, Liang J, Wei L, Li X, Zhou H, Yang C.
    Int Immunopharmacol; 2022 Dec 27; 113(Pt A):109316. PubMed ID: 36252483
    [Abstract] [Full Text] [Related]

  • 3. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J, Feng M, Sun R, Li Z, Hu L, Peng G, Xu X, Wang W, Cui F, Yue W, He J, Liu J.
    Toxicol Lett; 2020 Mar 15; 321():103-113. PubMed ID: 31706003
    [Abstract] [Full Text] [Related]

  • 4. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G, Shen C, Wei D, Yang X, Jiang C, Yang X, Mao W, Zou J, Tan J, Chen J.
    Lung; 2023 Apr 15; 201(2):235-242. PubMed ID: 36823409
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
    Ruan H, Gao S, Li S, Luan J, Jiang Q, Li X, Yin H, Zhou H, Yang C.
    Molecules; 2021 May 10; 26(9):. PubMed ID: 34068694
    [Abstract] [Full Text] [Related]

  • 8. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.
    Ruan H, Luan J, Gao S, Li S, Jiang Q, Liu R, Liang Q, Zhang R, Zhang F, Li X, Zhou H, Yang C.
    Molecules; 2021 Jul 26; 26(15):. PubMed ID: 34361644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway.
    Yin JZ, Li ZQ, Zhang XD, Wan ZJ, Qin HR, Yao LH, Li BL, Gao F, Yang YY.
    Eur J Pharmacol; 2024 Feb 05; 964():176293. PubMed ID: 38158113
    [Abstract] [Full Text] [Related]

  • 12. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
    Miao Y, Wang Y, Bi Z, Huang K, Gao J, Li X, Li S, Wei L, Zhou H, Yang C.
    BMC Pulm Med; 2023 Mar 22; 23(1):94. PubMed ID: 36949426
    [Abstract] [Full Text] [Related]

  • 13. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W, Zhang Y, Fang P, Shi H, Yang S.
    Environ Toxicol; 2022 Oct 22; 37(10):2375-2387. PubMed ID: 35785413
    [Abstract] [Full Text] [Related]

  • 14. Pazopanib attenuated bleomycin-induced pulmonary fibrosis via suppressing TGF-β1 signaling pathway.
    Huang K, Zhang Q, Ruan H, Guo C, Wu S, Liu Q, Zhang D, Long S, Wang W, Wu Z, Tian L, Gao S, Zhao H, Gu X, Yin H, Yang C.
    J Thorac Dis; 2024 Apr 30; 16(4):2244-2258. PubMed ID: 38738240
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y, Gochuico BR, Yu G, Tang X, Osorio JC, Fernandez IE, Risquez CF, Patel AS, Shi Y, Wathelet MG, Goodwin AJ, Haspel JA, Ryter SW, Billings EM, Kaminski N, Morse D, Rosas IO.
    Am J Respir Crit Care Med; 2013 Oct 01; 188(7):831-41. PubMed ID: 23924348
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y, Zhang D, Qian F, Wu Y.
    Int Immunopharmacol; 2019 Sep 01; 74():105696. PubMed ID: 31229901
    [Abstract] [Full Text] [Related]

  • 19. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S, Han JH, Kim S, Lee H, Kim JR, Lim JH, Woo CH.
    Cell Physiol Biochem; 2020 Feb 22; 54(2):195-210. PubMed ID: 32083406
    [Abstract] [Full Text] [Related]

  • 20. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib.
    Wang D, Wei Y, Xu L, Zhang J.
    Adv Rheumatol; 2023 May 16; 63(1):22. PubMed ID: 37194022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.